Wave Life Sciences (WVE) Other Accumulated Expenses (2014 - 2017)
Wave Life Sciences (WVE) posted Other Accumulated Expenses of $156000.0 for Q4 2017, down 83.54% on a QoQ basis from $948000.0 in Q4 2016, and down 83.54% year-over-year from $948000.0 in Q4 2016.
Wave Life Sciences (WVE) Other Accumulated Expenses (2014 - 2017) Analysis & Trends
Wave Life Sciences' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $156000.0 for Q4 2017.
- Quarterly Other Accumulated Expenses fell 83.54% year-over-year to $156000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $156000.0 (down 83.54% YoY) and the FY2017 annual result came in at $156000.0, down 83.54% from the prior year.
- Other Accumulated Expenses was $156000.0 for Q4 2017 at Wave Life Sciences, down from $948000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $948000.0 in Q4 2016 and bottomed at $156000.0 in Q4 2017.
- A 4-year average of $408000.0 and a median of $353000.0 in 2015 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2016 — Other Accumulated Expenses soared 168.56% — and 2017, when it plunged 83.54%.
- Wave Life Sciences' Other Accumulated Expenses stood at $177000.0 in 2014, then soared by 99.44% to $353000.0 in 2015, then surged by 168.56% to $948000.0 in 2016, then plunged by 83.54% to $156000.0 in 2017.
- Business Quant data shows WVE's Other Accumulated Expenses at $156000.0 in Q4 2017, $948000.0 in Q4 2016, and $353000.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 156,000.00 |
| Dec 31, 2016 | 948,000.00 |
| Dec 31, 2015 | 353,000.00 |
| Sep 30, 2015 | 406,000.00 |
| Dec 31, 2014 | 177,000.00 |